Alzai Health Corp.ALZI.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · alzaihealth.com
Healthcare technology company developing non-invasive, AI-driven disease risk identification from routine healthcare data — originally Alzheimer's risk screening, now expanding to liver disease via an exclusive worldwide license from MOR (Clalit Health Services) and Yeda (Weizmann Institute).
Recent news
ALZAI Health Corp. Posted for Trading on the Frankfurt Stock Exchange
Alzai Health Corp. Announces Marketing Services Agreement
ALZAI and Linus Health Explore AI-Driven Collaborations for Early Alzheimer's Risk Identification
ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology
Track ALZI.V in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer